Thursday, 2 July 2026
  
Login

Australia's most trusted
source of pharma news

Thursday, 2 July 2026
Ascott 1
Ascott 1
Latest News
Next era of blockbusters unveiled

The next crop of best-selling mega drugs has been unveiled including one franchise that is on track to become the most valuable in pharma history. See who's on the list and who's vanished.

Media frenzy bites AstraZeneca
A global decision to wind back a monthly hormone blocker has seen AstraZeneca Australia come under sustained fire in the media
TODAY
Top names lead closed-door event
Three well-known industry execs fronted a panel to discuss outsourcing as an increasingly important strategic growth lever
TODAY
Medscape
Medscape
Most Popular
Butler won't overrule PBS delisting
Dept calls for savage price cuts to two major drugs that treat almost half the Aussie patients suffering from MS
1 July
Six Aussie Country Leaders in limbo
A spate of departures from country leadership roles across ANZ has left six top operators in limbo and a number of job openings
30 June
Cancer patients pick No. 1 pharma
Companies selected for best corporate reputation but industry overall scolded for failing to improve access to innovative medicines
1 July
Troubled drug faces revocation
Concerns over a registrational trial have seen overseas authorities recommend removing approval for this PBS-listed drug
30 June
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (25)

Access & Reimbursement (2)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (6)

Executive Roles (5)

Other (12)

More News
July PBS listings climb to 13
Find out who the Health Minister forgot to mention in his PBS announcement as more companies celebrate good news
1 July New to the PBS
Agency sold for undisclosed sum
Acquisition further expands the company's medical and market access capabilities and strengthens its global presence
1 July
Half left uncovered by PBS
Patients Australia survey finds people are often prescribed drugs not covered by the PBS with many delaying treatment due to cost
1 July
Government expands vax funding
Data showing previously ineligible groups are at risk has prompted an expansion of the funded vaccine programs
1 July
J&J argues against 'far greater evil'
The pharma giant is seeking clarification on the size of a class action suit against it, while the applicants argue it would just produce 'useless information'
30 June
'Policy lag tax' hurting patients
The true cost of policy delays is costing patients and the payment due is far more expensive than cash dollars
30 June
TGA win lands just in time
This company has earned the regulator's nod for a drug which will be considered by the PBAC when it meets early next month
30 June
The PBS at its best, Mark. Really?
The Health Minister has curiously used a therapy that took almost five years to reach patients as an example of the PBS at its best
29 June
10 drugs score July PBS listings
The 10 PBS listings announced by Butler includes 2 new labels for one drug, and a drug yet to be recommended by the PBAC
29 June
Double PBS win for Novo
Two long-awaited drugs to join the scheme - one recommended by the PBAC three years ago and another TGA approved in 2017
29 June
NEXT-level Summit agenda reveal
The Day 1 Agenda for NEXT Pharma Summit Australia is out promising a no-holds-barred deep dive into the state of the industry
29 June
$59M drug under threat
The TGA has approved two new meds plus the first generics of two drugs - one which made over $59M on the PBS last year
29 June Approvals Action
Two days, two big deals for Arrotex
Company steams on, signing yet another deal - this time bringing an innovative medicine to ANZ in a space dominated by Big Pharmas
26 June
Aussie redundancies keep piling up
ICYMI: Another Big Pharma has announced it's downsizing its local team plus the other top stories this week
26 June Your Week in 5 Minutes
PiF Advertise
PiF Advertise
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe